betaine

FDA Drug Profile — Cystadane

betaine is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Cystadane. Available dosage form: powder, for solution.

Drug details

Generic Name
betaine
Brand Names
Cystadane
Application Number
NDA020576
Sponsor
Recordati Rare Diseases
NDC Codes
1
Dosage Forms
POWDER, FOR SOLUTION
Routes
ORAL
Active Ingredients
BETAINE

Indications and Usage

1 INDICATIONS & USAGE Betaine Anhydrous for Oral Solution is indicated for the treatment of homocystinuria to decrease elevated homocysteine blood concentrations in pediatric and adult patients. Included within the category of homocystinuria are Cystathionine beta-synthase (CBS) deficiency 5,10-methylenetetrahydrofolate reductase (MTHFR) deficiency Cobalamin cofactor metabolism (cbl) defect Betaine Anhydrous for Oral Solution is a methylating agent indicated in pediatric and adult patients for the treatment of homocystinuria to decrease elevated homocysteine blood concentrations. Included within the category of homocystinuria are: Cystathionine beta-synthase (CBS) deficiency 5,10-methylenetetrahydrofolate reductase (MTHFR) deficiency Cobalamin cofactor metabolism (cbl) defect

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.